Joseph Biskupiak, Gary Oderda, Diana Brixner, & Todd L Wandstrat. (2024). Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment comparison methods. Becaris Publishing Limited.
Chicago Style (17th ed.) CitationJoseph Biskupiak, Gary Oderda, Diana Brixner, and Todd L Wandstrat. Gastrointestinal Adverse Effects Associated with the Use of Intravenous Oliceridine Compared with Intravenous Hydromorphone or Fentanyl in Acute Pain Management Utilizing Adjusted Indirect Treatment Comparison Methods. Becaris Publishing Limited, 2024.
MLA (9th ed.) CitationJoseph Biskupiak, et al. Gastrointestinal Adverse Effects Associated with the Use of Intravenous Oliceridine Compared with Intravenous Hydromorphone or Fentanyl in Acute Pain Management Utilizing Adjusted Indirect Treatment Comparison Methods. Becaris Publishing Limited, 2024.